INSUBCONTINENT EXCLUSIVE:
Several months after discreetly acquiring the online prescription service HeyDoctor, GoodRx is launching a new service based on the
acquisition, GoodRx Care, and offering a direct challenge to online prescription services like Hims, Hers, Nurx, Ro and others.Already a
billion-dollar giant in the world of prescription fulfillment through its cost-comparison and discount medication fulfillment business, more
consultation, treatment, prescriptions and lab tests from doctors
The array of services on offer, which covers conditions and ailments from urinary tract infection treatments and birth control pills to
erectile dysfunction medication and hair replacement supplements, mirror those pitched by white-glove online prescription services like Ro,
company can keep those customers in-house by offering their own telemedicine consults.Other technology companies are also pushing deeper
into the healthcare industry, with Amazon making a big splash with the launch of its employee-only healthcare service offering telemedicine
and on-site consultations with staff doctors
Apple, too, has its own healthcare service for employees.Even Best Buy is seeing big dollars in the healthcare industry
It expects healthcare services to become an increasingly important component to its bottom line as more technology hardware and software is
developed to cater to both the aging population, remote health solutions and infant and childcare.Demand for more healthcare alternatives is
only increasing, even as the cost of care rises and the value of healthcare services declines.As GoodRx notes, access to primary care
physicians is hard for most Americans
doctors coming within the next 15 years
treatments, acne treatments, eyelash growth or metabolic assessments.Hirsch says more services will be coming in later months
price point down and having more control over where to refer customers
The terms of the acquisition were not disclosed.The acquisition of HeyDoctor is the first big strategic gambit from the company in the year
since it raised money from the private equity firm Silverlake in a transaction that valued the discount pharmaceutical provider at roughly
